Global Biopharma R&D Productivity And Growth Ranking
Overall Decline In R&D Productivity Continued In 2019
Executive Summary
An analysis of the R&D productivity of the world’s 30 largest public pharmaceutical companies reveals an overall drop in R&D productivity, but this should not hide the fact that some companies are still performing extremely well.